Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Cell Immunol
; 287(1): 1-17, 2014 Jan.
Article
em En
| MEDLINE
| ID: mdl-24342422
Palavras-chave
APC; BBB; CB1; CB2; CNS; Cannabinoid receptor; Chemokines; DC; EAE; FACS; Gp1a; LPS; MNCs; MOG; MS; PBS; PT; T cell receptor; TCR; Th17 differentiation; antigen-presenting cell; blood brain barrier; cannabinoid receptor 1; cannabinoid receptor 2; central nervous system; dendritic cell; experimental autoimmune encephalomyelitis; fluorescence activated cell sorter; lipopolysaccharide; mononuclear cells; multiple sclerosis; myelin oligodendrocyte glycoprotein; pertussis toxin; phosphate buffered saline; qRT-PCR; quantitative RT-PCR
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirazóis
/
Sistema Nervoso Central
/
Receptor CB2 de Canabinoide
/
Encefalomielite Autoimune Experimental
/
Células Th17
/
Indenos
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Cell Immunol
Ano de publicação:
2014
Tipo de documento:
Article
País de afiliação:
Estados Unidos